Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The mRNA and protein expression levels of B cell leukemia/lymphoma (Bcl‑2), Bcl‑2 associated X (Bax), cyclin dependent kinase 4 (CDK4), cyclin D1 and p21 were evaluated using reverse transcription‑polymerase chain reaction and western blot analysis, respectively.
|
29115462 |
2018 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunophenotypic analysis showed that the lymphoma cells were positive for cyclin D1 (n=16/16), Myc (9/11), and P53 (n=9/9).
|
27776009 |
2017 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Cyclin D1-positive large B-cell lymphoma is rare, but as large B-cell lymphoma is a common type of lymphoma, cyclin D1-positive large B-cell lymphoma should be considered a major possibility during differential diagnosis, including in the tonsils.
|
28296741 |
2017 |
Lymphoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Accordingly, this isotype was the most effective in eradicating BCL1 lymphoma but had limited efficacy in s.c. tumors.
|
29109120 |
2017 |
Lymphoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
A cohort comprising 156 patients with B-cell neoplasms harboring an MYC rearrangement was analyzed with respect to phenotypic presentation, molecular markers (TP53, MYC and ID3) and additional cytogenetic abnormalities (concomitantly occurring BCL2, BCL6 and/or CCND1 rearrangements; double, triple or quadruple hit lymphomas = multiple hit lymphomas).
|
27810071 |
2016 |
Lymphoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Mantle cell lymphoma (MCL) is a distinct subtype of malignant lymphoma which is characterized by the chromosomal translocation t(11;14)(q13;q32) resulting in constitutional overexpression of cyclin D1 and cell cycle dysregulation in almost all cases.
|
25015778 |
2015 |
Lymphoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Mantle cell lymphoma (MCL) characterized by the t(11;14)(q13;q32) translocation, resulting in cyclin D1 overexpression, is one of the most challenging lymphomas to treat.
|
23020673 |
2013 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
All 1292 reactive lymph nodes from unselected consecutive surgical specimens of 131 patients without a history of lymphoma obtained over a 3-month period were stained for cyclin D1.
|
22790016 |
2012 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The protein synthesis inhibitor silvestrol has potent activity in B-cell leukemias via the mitochondrial pathway of apoptosis, and also reduces cyclin D1 expression in breast cancer and lymphoma cell lines.
|
22791882 |
2012 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Cyclin D1 overexpression is a hallmark of mantle cell lymphoma, whereas cyclins D2 and D3 have not been shown to be closely associated with any particular subtype of lymphoma.
|
21790895 |
2011 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.
|
21281227 |
2011 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Thus, genetic or pharmacologic targeting of cyclin-D1 combined with a proapoptotic BH3 mimetic synergistically killed the cyclin-D1-expressing murine lymphomas, human MCL cell lines, and primary lymphoma cells.
|
21746927 |
2011 |
Lymphoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Two showed an additional IGH-CCND1/t(11;14)(q13;q32) as fourth genetic event (according to research of the Mitelman database, the first reports on four genetic hits in lymphomas).
|
20960563 |
2011 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Our results show that cyclin-D2 and D3 proteins are expressed in many more lymphoma subtypes than cyclin-D1.
|
20062012 |
2010 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We tested five reference genes for stability on our sample set and using the three most stable ones (YWHAZ, ubiquitin c, and HPRT) obtained rather small intra-group variance for cyclin D1 expression in most lymphomas.
|
20727381 |
2010 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Aberrant Cyclin D1 expression seems to promote proliferation in other types of lymphoma, while a growth promoting CCND1/TACSD1(TROP2) fusion product has also been described in tumors.
|
19554511 |
2009 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Its distinction from other lymphomas is important for prognosis and appropriate therapy, but occasional cases may fail to express CCND1 and morphologic simulators may express CD20 and CD5 but not CD23.
|
17934069 |
2008 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Cyclin D1 overexpression was found in 60/61 MCLs and in none of the other lymphomas, except for 12/19 mucosa-associated lymphoid tissue lymphomas from the lungs and stomach, which also revealed cyclin D1 overexpression.
|
18303407 |
2008 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
In human blood cancers, loss of Rb expression has been widely reported in both acute myeloblastic and acute lymphoblastic leukemias, cyclin D1 amplification is common in mantle cell lymphoma, and silencing of the p16/INK4a tumor suppressor gene occurs frequently in AML and various types of lymphoma.
|
15611658 |
2005 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
We implemented a system based on this specificity to investigate the mechanism of BCL1 lymphoma protection induced by DNA immunisation.
|
15692846 |
2005 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We managed a peculiar case of lymphoma showing immunohistochemical overexpression of cyclin D1.
|
15239399 |
2004 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Among the 23 validated genes were cyclin D1 (CCND1) and B-cell CLL/lymphoma 2, which have well-known roles in lymphoma pathogenesis.
|
14961037 |
2004 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We previously showed that p27 expression in MCL, as assessed by immunohistochemistry (IHC), does not show the usual inverse relationship to proliferate seen in most other lymphomas that do not overexpress cyclin D1.
|
12515730 |
2003 |
Lymphoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
As cyclin D1 overexpression is a common phenomenon in different cancers, BCL-6 protein overexpression may not be restricted to lymphomas.
|
14654791 |
2003 |
Lymphoma
|
0.100 |
Biomarker
|
group |
BEFREE |
A comprehensive cytogenetics approach including SKY and interphase FISH using probes for specific genes, such as IGH, BCL2, CCND1, and ALK, is a very useful ancillary diagnostic tool for lymphomas.
|
12742158 |
2003 |